Skip to main content
Erschienen in: Reviews in Endocrine and Metabolic Disorders 2/2018

20.10.2018

Black swans - neuroendocrine tumors of rare locations

verfasst von: Christian A. Koch, S. Petersenn

Erschienen in: Reviews in Endocrine and Metabolic Disorders | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Neuroendocrine neoplasms (NEN) are rare and heterogeneous. Therefore, they often remain unrecognized for many years, causing significant disease burden. We here report on four unusual NEN presentations including a metastatic NEN of the kidney, hypoglycemia caused by an insulin-like growth factor-2-oma (previously called non-islet-cell tumor hypoglycemia), multifocal pheochromocytoma in von Hippel Lindau syndrome, and ileal NEN metastatic to the heart. One could say that each one of these tumors were “black swans” and learning about them will increase further awareness of the spectrum of NEN.
Literatur
1.
Zurück zum Zitat Klöppel G, Dege K, Remmele W, Kapran Y, Tuzlali S, Modlin IM. Siegfried Oberndorfer: a tribute to his work and life between Munich, Kiel, Geneva, and Istanbul. Virchows Arch. 2007;451(Suppl 1):S3–7.CrossRef Klöppel G, Dege K, Remmele W, Kapran Y, Tuzlali S, Modlin IM. Siegfried Oberndorfer: a tribute to his work and life between Munich, Kiel, Geneva, and Istanbul. Virchows Arch. 2007;451(Suppl 1):S3–7.CrossRef
2.
Zurück zum Zitat Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–42.CrossRef Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–42.CrossRef
3.
Zurück zum Zitat WHO Classification of Tumours of Endocrine Organs. 4th Edition. Vol.10. Editors: Lloyd RV, Osamura RY, Kloppel G, Rosai J. ISBN 978-92-832-4493-6. WHO Blue Book Series 2017. WHO Classification of Tumours of Endocrine Organs. 4th Edition. Vol.10. Editors: Lloyd RV, Osamura RY, Kloppel G, Rosai J. ISBN 978-92-832-4493-6. WHO Blue Book Series 2017.
4.
Zurück zum Zitat Fasshauer M, Lincke T, Witzigmann H, Kluge R, Tannapfel A, Moche M, et al. Ectopic Cushing' syndrome caused by a neuroendocrine carcinoma of the mesentery. BMC Cancer. 2006;6:108.CrossRef Fasshauer M, Lincke T, Witzigmann H, Kluge R, Tannapfel A, Moche M, et al. Ectopic Cushing' syndrome caused by a neuroendocrine carcinoma of the mesentery. BMC Cancer. 2006;6:108.CrossRef
5.
Zurück zum Zitat Müssig K, Petersenn S, Wehrmann M, Horger M, Vierling P, Häring HU, et al. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia. Eur J Gastroenterol Hepatol. 2007;19(8):719–23.CrossRef Müssig K, Petersenn S, Wehrmann M, Horger M, Vierling P, Häring HU, et al. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia. Eur J Gastroenterol Hepatol. 2007;19(8):719–23.CrossRef
6.
Zurück zum Zitat Fottner C, Ferrata M, Weber MM. Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): when to consider, how to diagnose? Rev Endocr Metab Disord. 2017;18(4):393–410.CrossRef Fottner C, Ferrata M, Weber MM. Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): when to consider, how to diagnose? Rev Endocr Metab Disord. 2017;18(4):393–410.CrossRef
7.
Zurück zum Zitat Koch CA, Brouwers FM, Rosenblatt K, Burman KD, Davis MM, Vortmeyer AO, et al. Adrenal ganglioneuroma in a patient presenting with severe hypertension and diarrhea. Endocr Relat Cancer. 2003;10(1):99–107.CrossRef Koch CA, Brouwers FM, Rosenblatt K, Burman KD, Davis MM, Vortmeyer AO, et al. Adrenal ganglioneuroma in a patient presenting with severe hypertension and diarrhea. Endocr Relat Cancer. 2003;10(1):99–107.CrossRef
8.
Zurück zum Zitat Salgado LR, Fragoso MC, Knoepfelmacher M, Machado MC, Domenice S, Pereira MA, et al. Ectopic ACTH syndrome: our experience with 25 cases. Eur J Endocrinol. 2006;155(5):725–33.CrossRef Salgado LR, Fragoso MC, Knoepfelmacher M, Machado MC, Domenice S, Pereira MA, et al. Ectopic ACTH syndrome: our experience with 25 cases. Eur J Endocrinol. 2006;155(5):725–33.CrossRef
9.
Zurück zum Zitat Korytnaya E, Liu J, Camelo-Piragua S, Sullivan S, Auchus RJ, Barkan A. Ectopic prolactin secretion from a perivascular epithelioid cell tumor (PEComa). J Clin Endocrinol Metab. 2014;99(11):3960–4.CrossRef Korytnaya E, Liu J, Camelo-Piragua S, Sullivan S, Auchus RJ, Barkan A. Ectopic prolactin secretion from a perivascular epithelioid cell tumor (PEComa). J Clin Endocrinol Metab. 2014;99(11):3960–4.CrossRef
10.
Zurück zum Zitat Koch CA, Azumi N, Furlong MA, Jha RC, Kehoe TE, Trowbridge CH, et al. Carcinoid syndrome caused by an atypical carcinoid of the uterine cervix. J Clin Endocrinol Metab. 1999;84(11):4209–13.CrossRef Koch CA, Azumi N, Furlong MA, Jha RC, Kehoe TE, Trowbridge CH, et al. Carcinoid syndrome caused by an atypical carcinoid of the uterine cervix. J Clin Endocrinol Metab. 1999;84(11):4209–13.CrossRef
11.
Zurück zum Zitat Miehle K, Tannapfel A, Lamesch P, Borte G, Schenker E, Kluge R, et al. Pancreatic neuroendocrine tumor with ectopic adrenocorticotropin production upon second recurrence. J Clin Endocrinol Metab. 2004;89(8):3731–6.CrossRef Miehle K, Tannapfel A, Lamesch P, Borte G, Schenker E, Kluge R, et al. Pancreatic neuroendocrine tumor with ectopic adrenocorticotropin production upon second recurrence. J Clin Endocrinol Metab. 2004;89(8):3731–6.CrossRef
12.
Zurück zum Zitat Langton K, Gruber M, Masjkur J, Steenblock C, Peitzsch M, Meinel J, et al. Hypertensive crisis in pregnancy due to a metamorphosing pheochromocytoma with postdelivery Cushing's syndrome. Gynecol Endocrinol. 2018;34(1):20–4.CrossRef Langton K, Gruber M, Masjkur J, Steenblock C, Peitzsch M, Meinel J, et al. Hypertensive crisis in pregnancy due to a metamorphosing pheochromocytoma with postdelivery Cushing's syndrome. Gynecol Endocrinol. 2018;34(1):20–4.CrossRef
13.
Zurück zum Zitat Maton PN, Gardner JD, Jensen RT. Cushing's syndrome in patients with the Zollinger-Ellison syndrome. N Engl J Med. 1986;315(1):1–5.CrossRef Maton PN, Gardner JD, Jensen RT. Cushing's syndrome in patients with the Zollinger-Ellison syndrome. N Engl J Med. 1986;315(1):1–5.CrossRef
14.
Zurück zum Zitat Oki K, Yamane K, Oda Y, Kamei N, Watanabe H, Tominaga A, et al. Combined acromegaly and subclinical Cushing disease related to high-molecular-weight adrenocorticotropic hormone. J Neurosurg. 2009;110(2):369–73.CrossRef Oki K, Yamane K, Oda Y, Kamei N, Watanabe H, Tominaga A, et al. Combined acromegaly and subclinical Cushing disease related to high-molecular-weight adrenocorticotropic hormone. J Neurosurg. 2009;110(2):369–73.CrossRef
15.
Zurück zum Zitat Melcescu E, Gannon AW, Parent AD, Fratkin JF, Nicholas WC, Galhom A, et al. Silent or subclinical Corticotroph pituitary macroadenoma transforming into Cushing disease: 11-year follow-up. Neurosurgery. 2013;72(1):E144–6.CrossRef Melcescu E, Gannon AW, Parent AD, Fratkin JF, Nicholas WC, Galhom A, et al. Silent or subclinical Corticotroph pituitary macroadenoma transforming into Cushing disease: 11-year follow-up. Neurosurgery. 2013;72(1):E144–6.CrossRef
16.
Zurück zum Zitat Melcescu E, Hogan RB 2nd, Brown K, Boyd SA, Abell TL, Koch CA. The various faces of autoimmune endocrinopathies: non-tumoral hypergastrinemia in a patient with lymphocytic colitis and chronic autoimmune gastritis. Exp Mol Pathol. 2012;93(3):434–40.CrossRef Melcescu E, Hogan RB 2nd, Brown K, Boyd SA, Abell TL, Koch CA. The various faces of autoimmune endocrinopathies: non-tumoral hypergastrinemia in a patient with lymphocytic colitis and chronic autoimmune gastritis. Exp Mol Pathol. 2012;93(3):434–40.CrossRef
17.
Zurück zum Zitat Grozinsky-Glasberg S, Alexandraki KI, Angelousi A, Chatzellis E, Sougioultzis S, Kaltsas G. Gastric Carcinoids. Endocrinol Metab Clin N Am. 2018;47(3):645–60.CrossRef Grozinsky-Glasberg S, Alexandraki KI, Angelousi A, Chatzellis E, Sougioultzis S, Kaltsas G. Gastric Carcinoids. Endocrinol Metab Clin N Am. 2018;47(3):645–60.CrossRef
18.
Zurück zum Zitat East HE, Subauste JS, Gandhi A, Koch CA. About secondary causes of diabetes mellitus. J Miss State Med Assoc. 2012;53(11):380–3.PubMed East HE, Subauste JS, Gandhi A, Koch CA. About secondary causes of diabetes mellitus. J Miss State Med Assoc. 2012;53(11):380–3.PubMed
19.
Zurück zum Zitat Vinik A, Perry RR, Casellini C, Hughes MS, Feliberti E. Pathophysiology and Treatment of Pancreatic Neuroendocrine Tumors (PNETs): New Developments. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. 2018 Jun 12. https://www.ncbi.nlm.nih.gov/books/NBK279074/ Vinik A, Perry RR, Casellini C, Hughes MS, Feliberti E. Pathophysiology and Treatment of Pancreatic Neuroendocrine Tumors (PNETs): New Developments. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.​com, Inc.; 2000-. 2018 Jun 12. https://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK279074/​
20.
Zurück zum Zitat Vinik A, Hughes MS, Feliberti E, Perry RR, Casellini C, Sinesi M, Vingan H, Johnson L. Carcinoid Tumors. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. 2018 Feb 5. https://www.ncbi.nlm.nih.gov/books/NBK279162/ Vinik A, Hughes MS, Feliberti E, Perry RR, Casellini C, Sinesi M, Vingan H, Johnson L. Carcinoid Tumors. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.​com, Inc.; 2000-. 2018 Feb 5. https://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK279162/​
21.
Zurück zum Zitat Petersenn S, Koch CA. Neuroendocrine neoplasms - still a challenge despite major advances in clinical care with the development of specialized guidelines. Rev Endocr Metab Disord. 2017;18(4):373–8.CrossRef Petersenn S, Koch CA. Neuroendocrine neoplasms - still a challenge despite major advances in clinical care with the development of specialized guidelines. Rev Endocr Metab Disord. 2017;18(4):373–8.CrossRef
22.
Zurück zum Zitat Phillips J, East HE, French SE, Melcescu E, Hamilton RD, Nicholas WC, et al. What causes a prolactinoma to be aggressive or to become a pituitary carcinoma? Hormones. 2012;11(4):477–82.CrossRef Phillips J, East HE, French SE, Melcescu E, Hamilton RD, Nicholas WC, et al. What causes a prolactinoma to be aggressive or to become a pituitary carcinoma? Hormones. 2012;11(4):477–82.CrossRef
23.
Zurück zum Zitat Deutschbein T, Fassnacht M, Weismann D, Reincke M, Mann K, Petersenn S. Treatment of malignant phaeochromocytoma with a combination of cyclophosphamide, vincristine and dacarbazine: own experience and overview of the contemporary literature. Clin Endocrinol (Oxf). 2015;82(1):84–90.CrossRef Deutschbein T, Fassnacht M, Weismann D, Reincke M, Mann K, Petersenn S. Treatment of malignant phaeochromocytoma with a combination of cyclophosphamide, vincristine and dacarbazine: own experience and overview of the contemporary literature. Clin Endocrinol (Oxf). 2015;82(1):84–90.CrossRef
24.
Zurück zum Zitat Poeppel TD, Binse I, Petersenn S, Lahner H, Schott M, Antoch G, et al. Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors. Recent Results Cancer Res. 2013;194:353–71.CrossRef Poeppel TD, Binse I, Petersenn S, Lahner H, Schott M, Antoch G, et al. Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors. Recent Results Cancer Res. 2013;194:353–71.CrossRef
25.
Zurück zum Zitat Anlauf M, Schlenger R, Perren A, Bauersfeld J, Koch CA, Dralle H, et al. Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome. Am J Surg Pathol. 2006;30(5):560–74.CrossRef Anlauf M, Schlenger R, Perren A, Bauersfeld J, Koch CA, Dralle H, et al. Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome. Am J Surg Pathol. 2006;30(5):560–74.CrossRef
26.
Zurück zum Zitat Anlauf M, Bauersfeld J, Raffel A, Koch CA, Henopp T, Alkatout I, et al. Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia. Am J Surg Pathol. 2009;33(3):339–46.CrossRef Anlauf M, Bauersfeld J, Raffel A, Koch CA, Henopp T, Alkatout I, et al. Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia. Am J Surg Pathol. 2009;33(3):339–46.CrossRef
27.
Zurück zum Zitat Huang SC, Koch CA, Vortmeyer AO, Pack SD, Lichtenauer UD, Mannan P, et al. Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas. Cancer Res. 2000;60(22):6223–6.PubMed Huang SC, Koch CA, Vortmeyer AO, Pack SD, Lichtenauer UD, Mannan P, et al. Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas. Cancer Res. 2000;60(22):6223–6.PubMed
28.
Zurück zum Zitat Gläsker S, Neumann HPH, Koch CA, Vortmeyer A. Von Hippel-Lindau Disease. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth: MDText.com, Inc.; 2000-. 2018 Sep 12. https://www.ncbi.nlm.nih.gov/pubmed/25905347. Gläsker S, Neumann HPH, Koch CA, Vortmeyer A. Von Hippel-Lindau Disease. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth: MDText.​com, Inc.; 2000-. 2018 Sep 12. https://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​25905347.
29.
Zurück zum Zitat Pieterman CRC, de Laat JM, Twisk JWR, van Leeuwaarde RS, de Herder WW, Dreijerink KMA, et al. Van der Horst-Schrivers ANA, Drent ML, Bisschop PH, Havekes B, Borel Rinkes IHM, Vriens MR, Valk GD. Long-term natural course of small nonfunctional pancreatic neuroendocrine tumors in MEN1-results from the Dutch MEN1 study group. J Clin Endocrinol Metab. 2017;102(10):3795–805.CrossRef Pieterman CRC, de Laat JM, Twisk JWR, van Leeuwaarde RS, de Herder WW, Dreijerink KMA, et al. Van der Horst-Schrivers ANA, Drent ML, Bisschop PH, Havekes B, Borel Rinkes IHM, Vriens MR, Valk GD. Long-term natural course of small nonfunctional pancreatic neuroendocrine tumors in MEN1-results from the Dutch MEN1 study group. J Clin Endocrinol Metab. 2017;102(10):3795–805.CrossRef
30.
Zurück zum Zitat Tulipano G, Schulz S. Novel insights in somatostatin receptor physiology. Eur J Endocrinol. 2007;156(Suppl 1):S3–11.CrossRef Tulipano G, Schulz S. Novel insights in somatostatin receptor physiology. Eur J Endocrinol. 2007;156(Suppl 1):S3–11.CrossRef
31.
Zurück zum Zitat Angelousi A, Kaltsas G, Koumarianou A, Weickert MO, Grossman A. Chemotherapy in NETs: when and how. Rev Endocr Metab Disord. 2017;18(4):485–97.CrossRef Angelousi A, Kaltsas G, Koumarianou A, Weickert MO, Grossman A. Chemotherapy in NETs: when and how. Rev Endocr Metab Disord. 2017;18(4):485–97.CrossRef
32.
Zurück zum Zitat Pavel M, Valle JW, Eriksson B, Rinke A, Caplin M, Chen J, et al. ENETS consensus guidelines for the standards of Care in Neuroendocrine Neoplasms: systemic therapy - biotherapy and novel targeted agents. Neuroendocrinology. 2017;105(3):266–80.CrossRef Pavel M, Valle JW, Eriksson B, Rinke A, Caplin M, Chen J, et al. ENETS consensus guidelines for the standards of Care in Neuroendocrine Neoplasms: systemic therapy - biotherapy and novel targeted agents. Neuroendocrinology. 2017;105(3):266–80.CrossRef
33.
Zurück zum Zitat Woltering EA, Mamikunian PM, Zietz S, Krutzik SR, Go VL, Vinik AI, et al. Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumors. Pancreas. 2005;31(4):392–400.CrossRef Woltering EA, Mamikunian PM, Zietz S, Krutzik SR, Go VL, Vinik AI, et al. Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumors. Pancreas. 2005;31(4):392–400.CrossRef
34.
Zurück zum Zitat Romero FR, Rais-Bahrami S, Permpongkosol S, Fine SW, Kohanim S, Jarrett TW. Primary carcinoid tumors of the kidney. J Urol. 2006;176(6 Pt 1):2359–66.CrossRef Romero FR, Rais-Bahrami S, Permpongkosol S, Fine SW, Kohanim S, Jarrett TW. Primary carcinoid tumors of the kidney. J Urol. 2006;176(6 Pt 1):2359–66.CrossRef
35.
Zurück zum Zitat Shimbori M, Osaka K, Kawahara T, Kasahara R, Kawabata S, Makiyama K, et al. Large cell neuroendocrine carcinoma of the kidney with cardiac metastasis: a case report. J Med Case Rep. 2017;11(1):297.CrossRef Shimbori M, Osaka K, Kawahara T, Kasahara R, Kawabata S, Makiyama K, et al. Large cell neuroendocrine carcinoma of the kidney with cardiac metastasis: a case report. J Med Case Rep. 2017;11(1):297.CrossRef
36.
Zurück zum Zitat Gauthé M, Lièvre A, Alberini JL. Primary neuroendocrine tumor in a horseshoe kidney with positive 111In-Pentetreotide somatostatin receptor scintigraphy and negative 18F-DOPA PET/CT. Clin Nucl Med. 2015;40(11):e516–7.CrossRef Gauthé M, Lièvre A, Alberini JL. Primary neuroendocrine tumor in a horseshoe kidney with positive 111In-Pentetreotide somatostatin receptor scintigraphy and negative 18F-DOPA PET/CT. Clin Nucl Med. 2015;40(11):e516–7.CrossRef
37.
Zurück zum Zitat Maletzki P, Diener PA, Bjasch D, Schmid HP, Gramann T. Primary neuroendocrine tumor of the kidney. A rarity. Urologe A. 2015;54(6):844–8.CrossRef Maletzki P, Diener PA, Bjasch D, Schmid HP, Gramann T. Primary neuroendocrine tumor of the kidney. A rarity. Urologe A. 2015;54(6):844–8.CrossRef
38.
Zurück zum Zitat Mardi K, Negi L, Srivastava S. Well differentiated neuroendocrine tumor of the kidney: report of a rare case with review of literature. Indian J Pathol Microbiol. 2017;60(1):105–7.PubMed Mardi K, Negi L, Srivastava S. Well differentiated neuroendocrine tumor of the kidney: report of a rare case with review of literature. Indian J Pathol Microbiol. 2017;60(1):105–7.PubMed
39.
Zurück zum Zitat Moch H. Neuroendocrine tumors of the kidneys. Pathologe. 2015;36(3):278–82.CrossRef Moch H. Neuroendocrine tumors of the kidneys. Pathologe. 2015;36(3):278–82.CrossRef
40.
Zurück zum Zitat Gu X, Cheng M, Herrera GA. Kidney carcinoid tumor: histological, immunohistochemical and ultrastructural features. Ultrastruct Pathol. 2018;42(1):18–22.CrossRef Gu X, Cheng M, Herrera GA. Kidney carcinoid tumor: histological, immunohistochemical and ultrastructural features. Ultrastruct Pathol. 2018;42(1):18–22.CrossRef
41.
Zurück zum Zitat Claessens T, Weppler SA, van Geel M, Creytens D, Vreeburg M, Wouters B, et al. Neuroendocrine carcinoma in a patient with Birt-Hogg-Dubé syndrome. Nat Rev Urol. 2010;7(10):583–7.CrossRef Claessens T, Weppler SA, van Geel M, Creytens D, Vreeburg M, Wouters B, et al. Neuroendocrine carcinoma in a patient with Birt-Hogg-Dubé syndrome. Nat Rev Urol. 2010;7(10):583–7.CrossRef
42.
Zurück zum Zitat Dynkevich Y, Rother KI, Whitford I, Qureshi S, Galiveeti S, Szulc AL, et al. Tumors, IGF-2, and hypoglycemia: insights from the clinic, the laboratory, and the historical archive. Endocr Rev. 2013;34(6):798–826.CrossRef Dynkevich Y, Rother KI, Whitford I, Qureshi S, Galiveeti S, Szulc AL, et al. Tumors, IGF-2, and hypoglycemia: insights from the clinic, the laboratory, and the historical archive. Endocr Rev. 2013;34(6):798–826.CrossRef
43.
Zurück zum Zitat Murakami K, Nakamura Y, Felizola SJ, Morimoto R, Satoh F, Takanami K, et al. Pancreatic solitary fibrous tumor causing ectopic adrenocorticotropic hormone syndrome. Mol Cell Endocrinol. 2016;436:268–73.CrossRef Murakami K, Nakamura Y, Felizola SJ, Morimoto R, Satoh F, Takanami K, et al. Pancreatic solitary fibrous tumor causing ectopic adrenocorticotropic hormone syndrome. Mol Cell Endocrinol. 2016;436:268–73.CrossRef
44.
Zurück zum Zitat Yabuki H, Sakurada A, Niikawa H, Notsuda H, Endo C, Matsuda Y, et al. Serum β-hCG as an Indicator of recurrence after the complete resection of a malignant solitary fibrous tumor of the pleura. Ann Thorac Surg. 2016;102(6):e551–3.CrossRef Yabuki H, Sakurada A, Niikawa H, Notsuda H, Endo C, Matsuda Y, et al. Serum β-hCG as an Indicator of recurrence after the complete resection of a malignant solitary fibrous tumor of the pleura. Ann Thorac Surg. 2016;102(6):e551–3.CrossRef
45.
Zurück zum Zitat Osinga TE, van den Eijnden MH, Kema IP, Kerstens MN, Dullaart RP, de Jong WH, et al. Van der Horst-Schrivers AN. Unilateral and bilateral adrenalectomy for pheochromocytoma requires adjustment of urinary and plasma metanephrine reference ranges. J Clin Endocrinol Metab. 2013;98(3):1076–83.CrossRef Osinga TE, van den Eijnden MH, Kema IP, Kerstens MN, Dullaart RP, de Jong WH, et al. Van der Horst-Schrivers AN. Unilateral and bilateral adrenalectomy for pheochromocytoma requires adjustment of urinary and plasma metanephrine reference ranges. J Clin Endocrinol Metab. 2013;98(3):1076–83.CrossRef
46.
Zurück zum Zitat Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915–42.CrossRef Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915–42.CrossRef
47.
Zurück zum Zitat Majumdar S, Friedrich CA, Koch CA, Megason GC, Fratkin JD, Moll GW. Compound heterozygous mutation with a novel splice donor region DNA sequence variant in the succinate dehydrogenase subunit B gene in malignant paraganglioma. Pediatr Blood Cancer. 2010;54(3):473–5.CrossRef Majumdar S, Friedrich CA, Koch CA, Megason GC, Fratkin JD, Moll GW. Compound heterozygous mutation with a novel splice donor region DNA sequence variant in the succinate dehydrogenase subunit B gene in malignant paraganglioma. Pediatr Blood Cancer. 2010;54(3):473–5.CrossRef
48.
Zurück zum Zitat O'Shea T, Druce M. When should genetic testing be performed in patients with neuroendocrine tumours? Rev Endocr Metab Disord. 2017;18(4):499–515.CrossRef O'Shea T, Druce M. When should genetic testing be performed in patients with neuroendocrine tumours? Rev Endocr Metab Disord. 2017;18(4):499–515.CrossRef
49.
50.
Zurück zum Zitat Hannah-Shmouni F, Melcescu E, Koch CA. Testing for Endocrine Hypertension In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; .2000–.2016 Dec 30. Hannah-Shmouni F, Melcescu E, Koch CA. Testing for Endocrine Hypertension In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.​com, Inc.; .2000–.2016 Dec 30.
51.
Zurück zum Zitat Hannah-Shmouni F, Stratakis CA, Koch CA. Flushing in (neuro)endocrinology. Rev Endocr Metab Disord. 2016;17(3):373–80.CrossRef Hannah-Shmouni F, Stratakis CA, Koch CA. Flushing in (neuro)endocrinology. Rev Endocr Metab Disord. 2016;17(3):373–80.CrossRef
52.
Zurück zum Zitat Singer J, Werner F, Koch CA, Bartels M, Aigner T, Lincke T, et al. Ectopic Cushing's syndrome caused by a well differentiated ACTH-secreting neuroendocrine carcinoma of the ileum. Exp Clin Endocrinol Diabetes. 2010;118(8):524–9.CrossRef Singer J, Werner F, Koch CA, Bartels M, Aigner T, Lincke T, et al. Ectopic Cushing's syndrome caused by a well differentiated ACTH-secreting neuroendocrine carcinoma of the ileum. Exp Clin Endocrinol Diabetes. 2010;118(8):524–9.CrossRef
53.
Zurück zum Zitat Castillo JG, Naib T, Zacks JS, Adams DH. Echocardiography in functional midgut neuroendocrine tumors: when and how often. Rev Endocr Metab Disord. 2017;18(4):411–21.CrossRef Castillo JG, Naib T, Zacks JS, Adams DH. Echocardiography in functional midgut neuroendocrine tumors: when and how often. Rev Endocr Metab Disord. 2017;18(4):411–21.CrossRef
54.
Zurück zum Zitat Jann H, Wertenbruch T, Pape U, Ozcelik C, Denecke T, Mehl S, et al. A matter of the heart: myocardial metastases in neuroendocrine tumors. Horm Metab Res. 2010;42(13):967–76.CrossRef Jann H, Wertenbruch T, Pape U, Ozcelik C, Denecke T, Mehl S, et al. A matter of the heart: myocardial metastases in neuroendocrine tumors. Horm Metab Res. 2010;42(13):967–76.CrossRef
Metadaten
Titel
Black swans - neuroendocrine tumors of rare locations
verfasst von
Christian A. Koch
S. Petersenn
Publikationsdatum
20.10.2018
Verlag
Springer US
Erschienen in
Reviews in Endocrine and Metabolic Disorders / Ausgabe 2/2018
Print ISSN: 1389-9155
Elektronische ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-018-9473-0

Weitere Artikel der Ausgabe 2/2018

Reviews in Endocrine and Metabolic Disorders 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.